Ketamine for the treatment of refractory status epilepticus

Seizure

Volumn 30, Issue , 2015, Pages 14-20

  Fang, Yao ^a   Wang, Xuefeng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Epilepsy; Ketamine; Seizure; Status epilepticus (SE)

Indexed keywords

KETAMINE; ANTICONVULSIVE AGENT;

ANTICONVULSANT ACTIVITY; ARTICLE; CLINICAL PRACTICE; EPILEPTIC STATE; EVIDENCE BASED PRACTICE; HEART ARRHYTHMIA; HUMAN; HYPERSALIVATION; INTRACRANIAL PRESSURE; INTRAOCULAR PRESSURE; MENTAL DISEASE; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; REFRACTORY STATUS EPILEPTICUS; SIDE EFFECT; ANIMAL; DRUG RESISTANT EPILEPSY; STATUS EPILEPTICUS;

ANIMALS; ANTICONVULSANTS; DRUG RESISTANT EPILEPSY; HUMANS; KETAMINE; STATUS EPILEPTICUS;

EID: 84937928208     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2015.05.010     Document Type: Review

References (72)

1. S. Hocker, W.O. Tatum, S. LaRoche, and W.D. Freeman Refractory and super-refractory status epilepticus - an update Curr Neurol Neurosci Rep 14 2014 452
2. U. Kramer, C.S. Chi, K.L. Lin, N. Specchio, M. Sahin, H. Olson, and et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children Epilepsia 52 2011 1956 1965
3. R. Nabbout FIRES and IHHE: delineation of the syndromes Epilepsia 54 Suppl. 6 2013 54 56
4. G. Hunter, and B. Young Status epilepticus: a review, with emphasis on refractory cases Can J Neurol Sci 39 2012 157 169
5. G.M. Brophy, R. Bell, J. Claassen, B. Alldredge, T.P. Bleck, T. Glauser, and et al. Guidelines for the evaluation and management of status epilepticus Neurocrit Care 17 2012 3 23
6. J. Claassen, L.J. Hirsch, R.G. Emerson, J.E. Bates, T.B. Thompson, and S.A. Mayer Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus Neurology 57 2001 1036 1042
7. S.A. Mayer, J. Claassen, J. Lokin, F. Mendelsohn, L.J. Dennis, B.F. Fitzsimmons, and et al. Refractorystatus epilepticus: frequency, risk factors, and impact on outcome Arch Neurol 59 2002 205 210
8. D. McCarthy, G. Chen, D.H. Kaump, and C. Ensor General anesthetic and other pharmacological properties of 2-(O-chlorophenyl)-2-methylamino-cyclohexanone HCl (CI-58L) J New Drugs 5 1965 21 33
9. G. Corssen, M. Miyasaka, and E.F. Domino Changing concepts in pain control during surgery: dissociative anesthesia with CI-581. A progress report Anesth Analg 47 1968 746 759
10. Y. Kayama, and K. Iwama The EEG, evoked potentials, and single-unit activity during ketamine anesthesia in cats Anesthesiology 36 1972 316 328
11. G. Corssen, S.C. Little, and M. Tavakoli Ketamine and epilepsy Anesth Analg 53 1974 319 335
12. G.G. Celesia, R.C. Chen, and B.J. Bamforth Effects of ketamine in epilepsy Neurology 25 1975 169 172
13. Letter: effects of ketamine on the EEG in normals and epileptics Anesth Analg 55 1976 445 451
14. T.Z. Deeb, J. Maguire, and S.J. Moss Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures Epilepsia 53 Suppl. 9 2012 79 88
15. H.J. Feng, G.C. Mathews, C. Kao, and R.L. Macdonald Alterations of GABAA-receptor function and allosteric modulation during development of status epilepticus J Neurophysiol 99 2008 1285 1293
16. R. Dingledine, K. Borges, D. Bowie, and S.F. Traynelis The glutamate receptor ion channels Pharmacol Rev 51 1999 7 61
17. F.G. Freeman, M.F. Jarvis, and P.M. Duncan Phencyclidine raises kindled seizure thresholds Pharmacol Biochem Behav 16 1982 1009 1011
18. J.A. Aram, D. Martin, M. Tomczyk, S. Zeman, J. Millar, G. Pohler, and et al. Neocortical epileptogenesis in vitro: studies with N-methyl-d-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands J Pharmacol Exp Ther 248 1989 320 328
19. A.M. Mazarati, and C.G. Wasterlain N-methyl-d-aspartate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat Neurosci Lett 265 1999 187 190
20. J. Kapur, and E.W. Lothman NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures Epilepsy Res 5 1990 103 111
21. D.G. Fujikawa Neuroprotective effect of ketamine administered after status epilepticus onset Epilepsia 36 1995 186 195
22. B. Sinner, and B.M. Graf Ketamine Handb Exp Pharmacol 182 2008 313 333
23. O.N. Gofrit, D. Leibovici, J. Shemer, A. Henig, and S.C. Shapira Ketamine in the field: the use of ketamine for induction of anaesthesia before intubation in injured patients in the field Injury 28 1997 41 43
24. M.G. Annetta, D. Iemma, C. Garisto, C. Tafani, and R. Proietti Ketamine: new indications for an old drug Curr Drug Targets 6 2005 789 794
25. N. Gaspard, B. Foreman, L.M. Judd, J.N. Brenton, B.R. Nathan, B.M. McCoy, and et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study Epilepsia 54 2013 1498 1503
26. A. Rosati, L.M. Erario, L. Ilvento, C. Cecchi, T. Pisano, L. Mirabile, and et al. Efficacy and safety of ketamine in refractory status epilepticus in children Neurology 79 2012 2355 2358
27. L.D. Mewasingh, T. Skhara, A. Aeby, F.J. Christiaens, and B. Dan Oral ketamine in paediatric non-convulsive status epilepticus Seizure 12 2003 483 489
28. D.J. Borris, E.H. Bertram, and J. Kapur Ketamine controls prolonged status epilepticus Epilepsy Res 42 2000 117 122
29. A. Tarocco, E. Ballardini, and G. Garani Use of ketamine in a newborn with refractory status epilepticus: a case report Pediatr Neurol 51 2014 154 156
30. A.S. Synowiec, D.S. Singh, V. Yenugadhati, J.P. Valeriano, C.J. Schramke, and K.M. Kelly Ketamine use in the treatment of refractory status epilepticus Epilepsy Res 105 2013 183 188
31. F.A. Zeiler, A.M. Kaufmann, L.M. Gillman, M. West, and J. Silvaggio Ketamine for medically refractory status epilepticus after elective aneurysm clipping Neurocrit Care 19 2013 119 124
32. D. Esaian, D. Joset, C. Lazarovits, P.C. Dugan, and D. Fridman Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome Ann Pharmacother 47 2013 1569 1576
33. A.H. Kramer Early ketamine to treat refractory status epilepticus Neurocrit Care 16 2012 299 305
34. P.S. Yeh, H.N. Shen, and T.Y. Chen Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient Seizure 20 2011 723 726
35. C.Y. Hsieh, P.S. Sung, J.J. Tsai, and C.W. Hwang Terminating prolonged refractory status epilepticus using ketamine Clin Neuropharmacol 33 2010 165 167
36. H. Prüss, and M. Holtkamp Ketamine successfully terminates malignant status epilepticus Epilepsy Res 82 2008 219 222
37. U. Kramer, Z. Shorer, B. Ben-Zeev, T. Lerman-Sagie, H. GoldbergStern, and E. Lahat Severe refractory status epilepticus owing to presumed encephalitis J Child Neurol 20 2005 184 187
38. E.E. Ubogu, S.M. Sagar, A.J. Lerner, B.N. Maddux, J.I. Suarez, and M.A. Werz Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity Epilepsy Behav 4 2003 70 75
39. R.D. Sheth, and B.E. Gidal Refractory status epilepticus: response to ketamine Neurology 51 1998 1765 1766
40. M.C. Walker, R.S. Howard, S.J. Smith, D.H. Miller, S.D. Shorvon, and S.D. Hirsch Diagnosis and treatment of status epilepticus on a neurological intensive care unit QJM 89 1996 913 920
41. F.A. Zeiler, J. Teitelbaum, L.M. Gillman, and M. West NMDA antagonists for refractory seizures Neurocrit Care 20 2014 502 513
42. D. Lodge, and K.M. Johnson Noncompetitive excitatory amino acid receptor antagonists Trends Pharmacol Sci 11 1990 81 86
43. J.W. Olney, R.C. Collins, and R.S. Sloviter Excitotoxic mechanisms of epileptic brain damage Adv Neurol 1986 857 877
44. F. Gardoni, and M. Di Luca New targets for pharmacological intervention in the glutamatergic synapse Eur J Pharmacol 545 2006 2 10
45. J.N. Kew, and J.A. Kemp Ionotropic and metabotropic glutamate receptor structure and pharmacology Psychopharmacology 179 2005 4 29
46. B.K. Kohl, and G. Dannhardt The NMDA receptor complex: a promising target for novel antiepileptic strategies Curr Med Chem 8 2001 1275 1289
47. T.W. Stone, and J.I. Addae The pharmacological manipulation of glutamate receptors and neuroprotection Eur J Pharmacol 447 2002 285 296
48. A.L. do Nascimento, N.F. Dos Santos, F. Campos Pelágio, S. Aparecida Teixeira, E.A. de Moraes Ferrari, and F. Langone Neuronal degeneration and gliosis time-course in the mouse hippocampal formation after pilocarpine-induced status epilepticus Brain Res 1470 2012 98 110
49. D.E. Potter, and M. Choudhury Ketamine: repurposing and redefining a multifaceted drug Drug Discov Today 19 2014 1848 1854
50. F. Aroni, N. Iacovidou, I. Dontas, C. Pourzitaki, and T. Xanthos Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug J Clin Pharmacol 49 2009 957 964
51. D.G. Fujikawa The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus Brain Res 725 1996 11 22
52. R. Craven Ketamine Anaesthesia 62 2007 48 53
53. C. Andrade, S. Franca, M. Sampaio, A. Ribeiro, J.M. Oliveira, J.A.M. Ribeiro, and et al. Successful use of ketamine in pediatric super-refractory status epilepticus - case report Epilepsia 53 Suppl. 5 2012 98
54. W. Loscher Mechanisms of drug resistance in status epilepticus Epilepsia 48 Suppl. 8 2007 74 77
55. D.G. Fujikawa Prolonged seizure and cellular injury: understanding the connection Epilepsy Behav 7 Suppl. 3 2005 S3 S11
56. S. Gosselin-Lefebvre, A. Rabinstein, A. Rossetti, and M. Savard Ketamine usefulness in refractory status epilepticus: a retrospective multicenter study Can J Neurol Sci 40 2013 S31
57. A. Rosati, L.M. Erario, L. Ilvento, T. Pisano, L. Mirabile, and R. Guerrini An ongoing open-label uncontrolled study of the efficacy and safety of ketamine in children with refractory status epilepticus Epilepsia 54 Suppl. 3 2013 17
58. D.L. Reich, and G. Silvay Ketamine: an update on the first twenty five years of clinical experience Can J Anaesth 36 1989 186 197
59. S. Himmelseher, and M. Durieux Ketamine for perioperative pain management Anaesthesiology 102 2005 211 220
60. H. Takeshita, Y. Okuda, and A. Sari The effects of ketamine on cerebral circulation and metabolism in man Anaesthesiology 36 1972 69 75
61. F.A. Zeiler, J. Teitelbaum, M. West, and L.M. Gillman The ketamine effect on intracranial pressure in nontraumatic neurological illness J Crit Care 29 2014 1096 1106
62. S.A. Bergman Ketamine: review of its pharmacology and its use in pediatric anesthesia Anesth Prog 46 1999 10 20
63. M. Antal, G. Mucsi, and A. Faludi Ketamine anesthesia and intraocular pressure Ann Ophthalmol 10 1978 1281 1284 1289
64. A.G. Chandorkar, P.K. Jain, and M.V. Albal Modulations in intraocular pressure under ketamine anaesthesia Indian J Ophthalmol 23 1975 22 24
65. D. Blumberg, N. Congdon, H. Jampe, D. Gilbert, R. Elliott, R. Rivers, and et al. The effects of sevoflurane and ketamine on intraocular pressure in children during examination under anesthesia Am J Ophthalmol 143 2007 494 499
66. D.A. Haas, and D.G. Harper Ketamine: a review of its pharmacological properties and use in ambulatory anesthesia Anesth Prog 39 1992 61 68
67. A. Wutzler, M. Huemer, L.H. Boldt, A.S. Parwani, P. Attanasio, V. Tscholl, and et al. Effects of deep sedation on cardiac electrophysiology in patients undergoing radiofrequency ablation of supraventricular tachycardia: impact of propofol and ketamine Europace 15 2013 1019 1024
68. J.W. Olney, J. Labruyere, G. Wang, D.F. Wozniak, M.T. Price, and M.A. Sesma NMDA antagonist neurotoxicity: mechanism and prevention Science 254 1991 1515 1518
69. C. Wang, F. Liu, T. Patterson, M.G. Paule, and W. Slikker Jr. Preclinical assessment of ketamine CNS Neurosci Ther 19 2013 448 453
70. F. Dorandeu, F. Dhote, L. Barbier, B. Baccus, and G. Testylier Treatment of status epilepticus with ketamine, are we there yet CNS Neurosci Ther 19 2013 411 427
71. U.S. Food and Drug Administration KETALAR-ketamine hydrochloride injection 2013 Available from: www.fda.gov/safety/medwatch/safetyinformation/ucm299547.htm [accessed 10.12.14]
72. A. Fernandez, and J. Claassen Refractory status epilepticus Curr Opin Crit Care 18 2012 127 131